Clinical manufacturing of recombinant human interleukin 15. I. Production cell line development and protein expression in E. coli with stop codon optimization.
about
Characterization and favorable in vivo properties of heterodimeric soluble IL-15·IL-15Rα cytokine compared to IL-15 monomer.Obtention and characterization of the recombinant simian Interleukin-15 in Escherichia coli for the preclinical assessment of an IL-15-based therapeutic vaccine.A novel self-cleavable tag Zbasic-∆I-CM and its application in the soluble expression of recombinant human interleukin-15 in Escherichia coli.Purification of inclusion bodies using PEG precipitation under denaturing conditions to produce recombinant therapeutic proteins from Escherichia coli.
P2860
Clinical manufacturing of recombinant human interleukin 15. I. Production cell line development and protein expression in E. coli with stop codon optimization.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Clinical manufacturing of reco ...... with stop codon optimization.
@en
Clinical manufacturing of reco ...... with stop codon optimization.
@nl
type
label
Clinical manufacturing of reco ...... with stop codon optimization.
@en
Clinical manufacturing of reco ...... with stop codon optimization.
@nl
prefLabel
Clinical manufacturing of reco ...... with stop codon optimization.
@en
Clinical manufacturing of reco ...... with stop codon optimization.
@nl
P2093
P2860
P356
P1476
Clinical manufacturing of reco ...... with stop codon optimization.
@en
P2093
Dominic Esposito
George C Knapp
George Mitra
James Hartley
Jason L Yovandich
Jianwei Zhu
John M Roach
Man-Shiow Jiang
Stephen P Creekmore
Steven L Giardina
P2860
P304
P356
10.1002/BTPR.746
P577
2011-12-09T00:00:00Z